Skip to main content

Table 5 Pre-PFT questionnaires of BDTs

From: Clinical analysis of the “small plateau” sign on the flow-volume curve followed by deep learning automated recognition

Parameter

BDT (+)

BDT (−)

SP sign (+)

(N = 12)

SP sign (−)

(N = 2235)

P value

SP sign (+)

(N = 119)

SP sign (−)

(N = 3728)

P value

Smoking status, n (%)

  

.111

  

.005

 Current or former smoker

3 (25%)

1083 (48%)

 

45 (38%)

1929 (52%)

 

 Never smoker

9 (75%)

1172 (52%)

 

74 (62%)

1799 (48%)

 

Chronic cough, n (%)

  

.338

  

.270

 Rare

2 (17%)

625 (28%)

 

27 (23%)

1016 (27%)

 

 Sometimes

10 (83%)

1610 (72%)

 

92 (77%)

2712 (73%)

 

Sputum production, n (%)

9/12

(75%)

1559/2235

(70%)

1.000

75/119

(63%)

2651/3728

(71%)

.056

Wheezing, n (%)

11/12

(92%)

1234/2235

(55%)

.011

68/119

(57%)

1703/3728

(46%)

.014

PFT indication, n (%)

      

 Cough

2/12

(17%)

262/2235

(12%)

.643

8/119

(7%)

328/3728

(9%)

.430

 COPD

0/12

(0%)

809/2235

(34%)

.006

33/119

(28%)

1696/3728

(45%)

< .0001

 Asthma

10/12

(83%)

905/2235

(40%)

.002

38/119

(32%)

720/3728

(19%)

< .0001

 Bronchiectasis

0/12

(0%)

54/2235

(2%)

1.000

11/119

(9%)

293/3728

(8%)

.582

 ILD

0/12

(0%)

12/2235

(1%)

1.000

3/119

(3%)

70/3728

(2%)

.493

 Rhinitis/sinusitis

3/12

(25%)

18/2235

(1%)

< .0001

21/119

(18%)

39/3728

(1%)

< .0001

 Gastroesophageal reflux

0/12

(0%)

1/2235

(0%)

1.000

3/119

(3%)

0/3728

(0%)

< .0001

 Pneumonia

3/12

(25%)

56/2235

(3%)

.003

16/119

(13%)

210/3728

(6%)

< .0001

 Shortness of breath

1/12

(8%)

114/2235

(5%)

.468

5/119

(4%)

176/3728

(5%)

.792

 Chest distress

0/12

(0%)

9/2235

(0%)

1.000

2/119

(2%)

25/3728

(1%)

.203

 Othersa

0/12

(0%)

48/2235

(2%)

1.000

5/119

(4%)

171/3728

(5%)

.843

  1. Data are presented as absolute numbers in the case of frequencies. P values < .05 were considered to represent a significant difference in prevalence between SP signs of the negative and positive BDT categories
  2. COPD, chronic obstructive pulmonary disease; ILD, interstitial lung disease
  3. aIndications include hypertension, coronary heart disease, diabetes, eosinophilic granulomatosis with polyangiitis, and studies without documented indication